You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Desvenlafaxine

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Tokyo (Desvenlafaxine 100 mg, Desvenlafaxine 50 mg, Placebo)

Completed
  • Major Depressive Disorder
  • Desvenlafaxine 100 mg
  • +2 more
  • Tokyo, Japan
    Mochida Investigational sites
Sep 28, 2022

MDD Trial in Beijing (Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule

Completed
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule Placebo
  • +3 more
  • Beijing, China
    Beijing Anding Hospital
Dec 1, 2021

Study to Explore Antidepressant Treatment in Korea

Completed
  • Major Depression
  • Seoul, Korea, Republic of
    Pfizer
Nov 14, 2022

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Depressive Disorder, MDD Trial in United States (Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR))

Completed
Has Results
  • Depressive Disorder, Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)
  • Little Rock, Arkansas
  • +8 more
Aug 17, 2021

MDD, Neuroticism, Cognitive Change Trial in Farmington (Sertraline, bupropion, desvenlafaxine)

Recruiting
  • Major Depressive Disorder
  • +3 more
  • Sertraline, bupropion, desvenlafaxine
  • Farmington, Connecticut
    UConn Health
Mar 10, 2022

Depression, Opioid Dependence, Methadone Treatment Trial in Montréal (Desvenlafaxine)

Completed
  • Depression
  • +2 more
  • Desvenlafaxine
  • Montréal, Quebec, Canada
    Centre de recherche du Centre Hospitalier de l'Université de Mon
Oct 21, 2020

Depression, Anhedonia Trial in Toronto (Desvenlafaxine)

Completed
  • Depression
  • Anhedonia
  • Desvenlafaxine
  • Toronto, Ontario, Canada
    St. Michael's Hospital
Oct 28, 2020

MDD Trial in Worldwide (Vortioxetine, Desvenlafaxine)

Completed
  • Major Depressive Disorder
  • Banfield, Buenos Aires, Argentina
  • +79 more
Feb 11, 2022

Generalized Anxiety Disorder Trial in Toronto (Desvenlafaxine)

Completed
  • Generalized Anxiety Disorder
  • Desvenlafaxine
  • Toronto, Ontario, Canada
    START Clinic for Mood and Anxiety Disorders
Oct 21, 2020

Bipolar Disorder Therapies

Completed
  • Bipolar Disorder
  • Lithium Carbonate
  • +29 more
  • Albuquerque, New Mexico
    Christophe G Lambert
Sep 29, 2021

Hot Flashes, Breast Tumors Trial in Goyang, Seongnam, Seoul (Desvenlafaxine succinate 100mg, Desvenlafaxine succinate 50mg,

Terminated
  • Hot Flashes
  • Breast Neoplasms
  • Desvenlafaxine succinate 100mg
  • +2 more
  • Goyang, Gyeonggi-do, Korea, Republic of
  • +2 more
Sep 18, 2019

Depressive Disorder, Major Trial in United States (SAGE-217, Matching Placebo, Sertraline)

Completed
  • Depressive Disorder, Major
  • Dothan, Alabama
  • +50 more
Feb 28, 2022

Implementation of Personalized Medicine for Optimal Drug Therapy

Not yet recruiting
  • Nausea With Vomiting Chemotherapy-Induced
  • +2 more
  • Pharmacogenetic testing
  • Drug-Drug interaction analysis
  • London, Ontario, Canada
    Lawson Health Research Institute
Apr 13, 2023

Switching From SSRI to Desvenlafaxine on Cognitive Functioning

Unknown status
  • Major Depressive Disorder
  • Desvenlafaxine
  • Sabadell, Spain
    Corporació Sanitària Parc Taulí
Apr 17, 2019

MDD Trial in Baltimore (LY03005)

Completed
  • Major Depressive Disorder
  • Baltimore, Maryland
    Pharmaron CPC, Inc.
Aug 5, 2019

MDD Trial in Japan (desvenlafaxine succinate sustained release tablets)

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release tablets
  • Aichi, Japan
  • +16 more
Nov 15, 2018

Healthy Subjects Trial in New Haven (Venlafaxine, Moxifloxacin, Drug - )

Completed
  • Healthy Subjects
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Jan 26, 2021

Antidepressants in Advance of Investigational Trials

Recruiting
  • Major Depressive Disorder
  • FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
  • Watertown, Massachusetts
    Adams Clinical
Mar 9, 2021

Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

Recruiting
  • Depression
  • +6 more
  • Good Days Ahead (GDA)
  • +3 more
  • Indianapolis, Indiana
    IUPUI Department of Psychology
Jan 18, 2022

MDD Trial in Baltimore (LY03005, Pristiq)

Completed
  • Major Depressive Disorder
  • Baltimore, Maryland
    Pharmaron CPC, Inc.
Nov 7, 2018

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

Postmenopause, Hot Flashes Trial in Mexico City (Fluoxetine 20 MG, Citalopram 20mg)

Completed
  • Postmenopause
  • Hot Flashes
  • Fluoxetine 20 MG
  • Citalopram 20mg
  • Mexico City, Mexico
    Peri-postmenopause and bone metabolism clinic. Regional Hospital
Jul 25, 2022

Major Depression, Cancer, Diabetes Trial in Farmington (Desvenlafaxine, Omega 3 Fatty acids, Placebo (for Omega 3 fatty acid

Terminated
Has Results
  • Major Depression
  • +3 more
  • Desvenlafaxine
  • +2 more
  • Farmington, Connecticut
    University of Connecticut Health Center
Nov 30, 2017

MDD Trial in Eatontown (LY03005, Pristiq)

Completed
  • Major Depressive Disorder
  • Eatontown, New Jersey
    Clinilabs, Inc.
Jan 2, 2018